Prostate malignancy (PCa) is the second leading cause of cancer-related death in males, second only to lung malignancy, mainly due to disease reoccurrence as a result to lack of response to androgen deprivation therapies (ADT) after castration. in mCRPC that is critical for the modulation of level of sensitivity to chemotherapeutics. Therefore, these data determine… Continue reading Prostate malignancy (PCa) is the second leading cause of cancer-related death